Treatment and Implications of Vascular Endothelial Growth Factor Inhibitor‐Induced Blood Pressure Rise: A Clinical Cohort Study

Treatment and Implications of Vascular Endothelial Growth Factor Inhibitor‐Induced Blood Pressure Rise: A Clinical Cohort Study

Background Anti‐cancer vascular endothelial growth factor inhibitors (VEGFI) frequently induce a rise in blood pressure (BP). The most effective treatment of this BP rise is currently unknown, and risk factors and its association with survival remain inconclusive. Methods and Results Baseline charac...

Full description

Bibliographic Details
Main Authors: Daan C. H. van Dorst, Sumeyye Kabadayi, Esther Oomen‐de Hoop, A.H. Jan Danser, Ron H. J. Mathijssen, Jorie Versmissen
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
antihypertensive agents
cardio‐oncology
hypertension
survival
vascular endothelial growth factor inhibitor
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.122.028050

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.122.028050

Similar Items